Treatment Options for Soft Tissue Sarcoma
Soft Tissue Sarcoma (STS) is a type of cancer that originates in the soft tissues of the body. These tissues include muscles, tendons, fat, blood vessels, lymph vessels, nerves, and tissues around joints.
The objective of treatment for STS depends on various factors, including the stage and extent of the cancer. The treatment goals can range from curative to slowing the progression of the disease or controlling symptoms. Here are some key points to consider:
- If STS is diagnosed at an early stage, the goal of treatment may be to completely remove the cancer and achieve a cure. In these cases, surgery may be performed to remove the tumor.
- In more advanced cases, where complete removal of the cancer may not be possible, the focus shifts towards managing symptoms and preventing further progression of the disease. Treatment options in such cases may include a combination of surgery, radiation therapy, chemotherapy, targeted therapy, or immunotherapy.
- Immune checkpoint inhibitor therapy, such as pembrolizumab, nivolumab, or ipilimumab, may be offered as part of a clinical trial for recurrent STS.
It's important to note that each case of STS is unique, and treatment approaches will vary based on factors such as the specific type and extent of the cancer. The ultimate goal is to provide the most effective treatment strategy tailored to each individual's needs and circumstances.
The recommended potential treatments for STS can vary depending on the stage of the disease. Here are the treatment options starting with the initial recommended treatment:
- Surgery: Surgery is the most common treatment for STS. It involves removing the tumor and surrounding tissue to prevent recurrence.
- In some cases, a wide surgical excision with negative tissue margins in all directions is performed. This means removing a margin of healthy tissue around the tumor to ensure that no cancer cells are left behind.
- In rare cases, a specialized surgical technique called Mohs surgery may be considered for small, well-differentiated sarcomas of the skin to preserve cosmetic results.
- Radiation Therapy: Radiation therapy may be used in combination with surgery or as a standalone treatment for STS. It involves using high-energy beams to kill cancer cells and shrink tumors.
- Preoperative radiation therapy (preRT) or postoperative radiation therapy (PORT) may be recommended depending on the specific situation. Radiation therapy can help destroy any remaining cancer cells after surgery or reduce tumor size before surgery.
- Chemotherapy: Chemotherapy is not typically administered to patients with Stage I STS due to its low metastatic potential. However, for recurrent or Stage IV STS, chemotherapy may be considered as a treatment option.
- Chemotherapy involves using drugs to kill cancer cells throughout the body. Doxorubicin is a commonly used chemotherapy drug for managing metastatic STS. Other drugs that may have clinical activity include ifosfamide, gemcitabine, trabectedin, and taxanes.
- Targeted Therapy: Targeted therapy is a type of treatment that specifically targets certain molecules or pathways involved in cancer growth and progression. It is used for certain types of sarcomas or those in more advanced stages.
- Targeted therapy drugs work by interfering with specific proteins or genes that are necessary for cancer cell growth and survival.
- Immunotherapy: Immunotherapy is another type of treatment that helps boost the body's immune system to fight cancer cells.
- Immune checkpoint inhibitor therapy, such as pembrolizumab, nivolumab, or ipilimumab, may be offered as part of a clinical trial for recurrent STS.
In addition to medical treatments, lifestyle behavior modifications such as quitting smoking, alcohol moderation, nutrition and diet changes, and activity changes may also play a role in overall health and well-being during and after treatment for STS. However, it's important to consult with a healthcare professional before making any significant lifestyle changes.
It's important to note that these are general recommendations and individualized treatment plans should be discussed with a healthcare professional specializing in sarcoma treatment. They will consider factors such as the stage and location of the tumor, overall health, and patient preferences when determining the best course of action.